{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:21:59Z","timestamp":1761920519703},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41440-018-0107-4","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T03:17:11Z","timestamp":1538018231000},"page":"993-999","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical implication of visit-to-visit blood pressure variability"],"prefix":"10.1038","volume":"41","author":[{"given":"Satoshi","family":"Hoshide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"107_CR1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 esh\/esc guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281\u2013357.","journal-title":"J Hypertens"},{"key":"107_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37:253\u2013387.","journal-title":"Hypertens Res"},{"key":"107_CR3","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269\u2013324.","DOI":"10.1161\/HYP.0000000000000066"},{"key":"107_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895\u2013905.","journal-title":"Lancet"},{"key":"107_CR5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103\u201316.","journal-title":"N Engl J Med"},{"key":"107_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","volume":"9","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahlof B, et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 2010;9:469\u201380.","journal-title":"Lancet Neurol"},{"key":"107_CR7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","volume":"375","author":"AJ Webb","year":"2010","unstructured":"Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906\u201315.","journal-title":"Lancet"},{"key":"107_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.amjhyper.2003.09.008","volume":"17","author":"K Eguchi","year":"2004","unstructured":"Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, et al. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens. 2004;17:112\u20137.","journal-title":"Am J Hypertens"},{"key":"107_CR9","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/HJH.0000000000000668","volume":"33","author":"H Rakugi","year":"2015","unstructured":"Rakugi H, Ogihara T, Saruta T, Kawai T, Saito I, Teramukai S, et al. Preferable effects of olmesartan\/calcium channel blocker to olmesartan\/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens. 2015;33:2165\u201372.","journal-title":"J Hypertens"},{"key":"107_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/M14-2803","volume":"163","author":"P Muntner","year":"2015","unstructured":"Muntner P, Whittle J, Lynch AI, Colantonio LD, Simpson LM, Einhorn PT, et al. Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: a cohort study. Ann Intern Med. 2015;163:329\u201338.","journal-title":"Ann Intern Med"},{"key":"107_CR11","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1161\/CIRCULATIONAHA.113.002717","volume":"128","author":"J Hata","year":"2013","unstructured":"Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The ADVANCE trial. Circulation. 2013;128:1325\u201334.","journal-title":"Circulation"},{"key":"107_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2215\/CJN.10131012","volume":"8","author":"CJ McMullan","year":"2013","unstructured":"McMullan CJ, Bakris GL, Phillips RA, Forman JP. Association of BP variability with mortality among African Americans with CKD. Clin J Am Soc Nephrol. 2013;8:731\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"107_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.107565","volume":"126","author":"G Mancia","year":"2012","unstructured":"Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation. 2012;126:569\u201378.","journal-title":"Circulation"},{"key":"107_CR14","doi-asserted-by":"publisher","first-page":"e103169","DOI":"10.1371\/journal.pone.0103169","volume":"9","author":"A Hara","year":"2014","unstructured":"Hara A, Thijs L, Asayama K, Jacobs L, Wang JG, Staessen JA. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the systolic hypertension in Europe trial. PLoS ONE. 2014;9:e103169.","journal-title":"PLoS ONE"},{"key":"107_CR15","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/HYPERTENSIONAHA.117.09788","volume":"70","author":"TI Chang","year":"2017","unstructured":"Chang TI, Reboussin DM, Chertow GM, Cheung AK, Cushman WC, Kostis WJ, et al. Visit-to-visit office blood pressure variability and cardiovascular outcomes in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2017;70:751\u20138.","journal-title":"Hypertension"},{"key":"107_CR16","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1161\/STROKEAHA.111.626747","volume":"42","author":"A Zanchetti","year":"2011","unstructured":"Zanchetti A. Wars, war games, and dead bodies on the battlefield: variations on the theme of blood pressure variability. Stroke. 2011;42:2722\u20134.","journal-title":"Stroke"},{"key":"107_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/HYPERTENSIONAHA.117.10144","volume":"70","author":"Y Yano","year":"2017","unstructured":"Yano Y, Reis JP, Levine DA, Bryan RN, Viera AJ, Shimbo D, et al. Visit-to-visit blood pressure variability in young adulthood and hippocampal volume and integrity at middle age: The CARDIA study. Hypertension. 2017;70:1091\u20138.","journal-title":"Hypertension"},{"key":"107_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/HYPERTENSIONAHA.117.10385","volume":"71","author":"S Hoshide","year":"2018","unstructured":"Hoshide S, Yano Y, Mizuno H, Kanegae H, Kario K. Day-by-day variability of home blood pressure and incident cardiovascular disease in clinical practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure). Hypertension. 2018;71:177\u201384.","journal-title":"Hypertension"},{"key":"107_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrcardio.2013.1","volume":"10","author":"G Parati","year":"2013","unstructured":"Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143\u201355.","journal-title":"Nat Rev Cardiol"},{"key":"107_CR20","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2015.09.007","volume":"66","author":"D Tientcheu","year":"2015","unstructured":"Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol. 2015;66:2159\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"107_CR21","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1001\/jama.291.11.1342","volume":"291","author":"G Bobrie","year":"2004","unstructured":"Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of \u201cmasked hypertension\u201d detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342\u20139.","journal-title":"JAMA"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0107-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0107-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0107-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:19:28Z","timestamp":1684617568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0107-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0107-4","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]},"assertion":[{"value":"11 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Hoshide reports receiving speaker fee from Takeda Pharmaceutical Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}